175 related articles for article (PubMed ID: 18751969)
1. 18-methoxycoronaridine: a potential new treatment for obesity in rats?
Taraschenko OD; Rubbinaccio HY; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2008 Dec; 201(3):339-50. PubMed ID: 18751969
[TBL] [Abstract][Full Text] [Related]
2. Effects of 18-methoxycoronaridine on ghrelin-induced increases in sucrose intake and accumbal dopamine overflow in female rats.
McCallum SE; Taraschenko OD; Hathaway ER; Vincent MY; Glick SD
Psychopharmacology (Berl); 2011 May; 215(2):247-56. PubMed ID: 21210086
[TBL] [Abstract][Full Text] [Related]
3. Resistance of male Sprague-Dawley rats to sucrose-induced obesity: effects of 18-methoxycoronaridine.
Taraschenko OD; Maisonneuve IM; Glick SD
Physiol Behav; 2011 Feb; 102(2):126-31. PubMed ID: 20951714
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in high fat-induced obesity in rats: Effects of 18-methoxycoronaridine.
Taraschenko OD; Maisonneuve IM; Glick SD
Physiol Behav; 2011 Jun; 103(3-4):308-14. PubMed ID: 21324333
[TBL] [Abstract][Full Text] [Related]
5. 18-Methoxycoronaridine, a potential anti-obesity agent, does not produce a conditioned taste aversion in rats.
Taraschenko OD; Maisonneuve IM; Glick SD
Pharmacol Biochem Behav; 2010 Sep; 96(3):247-50. PubMed ID: 20457177
[TBL] [Abstract][Full Text] [Related]
6. 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens.
Taraschenko OD; Shulan JM; Maisonneuve IM; Glick SD
Synapse; 2007 Jul; 61(7):547-60. PubMed ID: 17447255
[TBL] [Abstract][Full Text] [Related]
7. Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration.
Glick SD; Sell EM; Maisonneuve IM
Eur J Pharmacol; 2008 Dec; 599(1-3):91-5. PubMed ID: 18930043
[TBL] [Abstract][Full Text] [Related]
8. The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment.
Szumlinski KK; Maisonneuve IM; Glick SD
Brain Res; 2000 May; 864(1):13-23. PubMed ID: 10793182
[TBL] [Abstract][Full Text] [Related]
9. Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens.
Zhang M; Kelley AE
Psychopharmacology (Berl); 2002 Feb; 159(4):415-23. PubMed ID: 11823894
[TBL] [Abstract][Full Text] [Related]
10. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
Glick SD; Maisonneuve IM; Szumlinski KK
Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
[TBL] [Abstract][Full Text] [Related]
11. 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats.
Glick SD; Ramirez RL; Livi JM; Maisonneuve IM
Eur J Pharmacol; 2006 May; 537(1-3):94-8. PubMed ID: 16626688
[TBL] [Abstract][Full Text] [Related]
12. α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo.
McCallum SE; Cowe MA; Lewis SW; Glick SD
Neuropharmacology; 2012 Sep; 63(3):434-40. PubMed ID: 22561751
[TBL] [Abstract][Full Text] [Related]
13. Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment.
Maisonneuve IM; Glick SD
Pharmacol Biochem Behav; 2003 Jun; 75(3):607-18. PubMed ID: 12895678
[TBL] [Abstract][Full Text] [Related]
14. The α3β4 nicotinic acetylcholine receptor antagonist 18-Methoxycoronaridine decreases binge-like ethanol consumption in adult C57BL/6J mice.
Miller CN; Ruggery C; Kamens HM
Alcohol; 2019 Sep; 79():1-6. PubMed ID: 30496781
[TBL] [Abstract][Full Text] [Related]
15. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.
Glick SD; Kuehne ME; Maisonneuve IM; Bandarage UK; Molinari HH
Brain Res; 1996 May; 719(1-2):29-35. PubMed ID: 8782860
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.
Maisonneuve IM; Glick SD
Eur J Pharmacol; 1999 Oct; 383(1):15-21. PubMed ID: 10556676
[TBL] [Abstract][Full Text] [Related]
17. 18-Methoxycoronaridine acts in the medial habenula to attenuate behavioral and neurochemical sensitization to nicotine.
Eggan BL; McCallum SE
Behav Brain Res; 2016 Jul; 307():186-93. PubMed ID: 27059333
[TBL] [Abstract][Full Text] [Related]
18. Interactions between 18-methoxycoronaridine (18-MC) and cocaine: dissociation of behavioural and neurochemical sensitization.
Szumlinski KK; McCafferty CA; Maisonneuve IM; Glick SD
Brain Res; 2000 Jul; 871(2):245-58. PubMed ID: 10899291
[TBL] [Abstract][Full Text] [Related]
19. Episodic sucrose intake during food restriction increases synaptic abundance of AMPA receptors in nucleus accumbens and augments intake of sucrose following restoration of ad libitum feeding.
Peng XX; Lister A; Rabinowitsch A; Kolaric R; Cabeza de Vaca S; Ziff EB; Carr KD
Neuroscience; 2015 Jun; 295():58-71. PubMed ID: 25800309
[TBL] [Abstract][Full Text] [Related]
20. GS 455534 selectively suppresses binge eating of palatable food and attenuates dopamine release in the accumbens of sugar-bingeing rats.
Bocarsly ME; Hoebel BG; Paredes D; von Loga I; Murray SM; Wang M; Arolfo MP; Yao L; Diamond I; Avena NM
Behav Pharmacol; 2014 Apr; 25(2):147-57. PubMed ID: 24603339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
